News Headlines Article

F.D.A. Approves Drugs for Cancer and Myeloma
New York Times

New drugs for breast cancer and multiple myeloma won approval from the Food and Drug Administration on Friday, expanding options for patients in advanced stages of those diseases.

The breast cancer drug, Afinitor from Novartis, seems to expand the time that endocrine therapy can keep the disease in check. The multiple myeloma drug, Kyprolis from Onyx Pharmaceuticals, was approved for use when at least two other drugs have failed.